Koninklijke Philips NV (PHIA) - Net Assets
Based on the latest financial reports, Koninklijke Philips NV (PHIA) has net assets worth €10.58 Billion EUR as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€26.34 Billion) and total liabilities (€15.76 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €10.58 Billion |
| % of Total Assets | 40.18% |
| Annual Growth Rate | 1.58% |
| 5-Year Change | 1.19% |
| 10-Year Change | 2.23% |
| Growth Volatility | 20.12 |
Koninklijke Philips NV - Net Assets Trend (1987–2024)
This chart illustrates how Koninklijke Philips NV's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Koninklijke Philips NV (1987–2024)
The table below shows the annual net assets of Koninklijke Philips NV from 1987 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €12.04 Billion | -0.15% |
| 2023-12-31 | €12.06 Billion | -9.20% |
| 2022-12-31 | €13.28 Billion | -8.23% |
| 2021-12-31 | €14.47 Billion | +21.62% |
| 2020-12-31 | €11.90 Billion | -5.73% |
| 2019-12-31 | €12.62 Billion | +4.19% |
| 2018-12-31 | €12.12 Billion | +0.78% |
| 2017-12-31 | €12.02 Billion | -10.99% |
| 2016-12-31 | €13.51 Billion | +14.67% |
| 2015-12-31 | €11.78 Billion | +7.40% |
| 2014-12-31 | €10.97 Billion | -2.31% |
| 2013-12-31 | €11.23 Billion | +0.47% |
| 2012-12-31 | €11.17 Billion | -9.81% |
| 2011-12-31 | €12.39 Billion | -17.91% |
| 2010-12-31 | €15.09 Billion | +3.06% |
| 2009-12-31 | €14.64 Billion | -6.09% |
| 2008-12-31 | €15.59 Billion | -28.34% |
| 2007-12-31 | €21.76 Billion | -5.91% |
| 2006-12-31 | €23.13 Billion | +36.17% |
| 2005-12-31 | €16.98 Billion | +12.25% |
| 2004-12-31 | €15.13 Billion | +17.15% |
| 2003-12-31 | €12.92 Billion | -8.47% |
| 2002-12-31 | €14.11 Billion | -24.49% |
| 2001-12-31 | €18.69 Billion | -16.08% |
| 2000-12-31 | €22.27 Billion | +47.13% |
| 1999-12-31 | €15.13 Billion | +5.39% |
| 1998-12-31 | €14.36 Billion | +46.41% |
| 1997-12-31 | €9.81 Billion | +37.44% |
| 1996-12-31 | €7.14 Billion | +4.62% |
| 1995-12-31 | €6.82 Billion | +0.59% |
| 1994-12-31 | €6.78 Billion | +12.55% |
| 1993-12-31 | €6.03 Billion | +46.01% |
| 1992-12-31 | €4.13 Billion | -28.70% |
| 1991-12-31 | €5.79 Billion | +1.16% |
| 1990-12-31 | €5.72 Billion | -32.20% |
| 1989-12-31 | €8.44 Billion | +19.61% |
| 1988-12-31 | €7.05 Billion | +4.47% |
| 1987-12-31 | €6.75 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Koninklijke Philips NV's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2.9% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €3.65 Billion | 30.40% |
| Common Stock | €188.00 Million | 1.57% |
| Other Comprehensive Income | €1.93 Billion | 16.03% |
| Other Components | €6.24 Billion | 52.00% |
| Total Equity | €12.01 Billion | 100.00% |
Koninklijke Philips NV Competitors by Market Cap
The table below lists competitors of Koninklijke Philips NV ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
DexCom Inc
NASDAQ:DXCM
|
$24.62 Billion |
|
ANTA Sports Products Limited
F:AS7
|
$24.66 Billion |
|
PulteGroup Inc
NYSE:PHM
|
$24.66 Billion |
|
Holcim Ltd.
LSE:0QKY
|
$24.67 Billion |
|
Shengyi Technology Co Ltd
SHG:600183
|
$24.62 Billion |
|
Cathay Financial Holding Co Ltd Pref A
TW:2882A
|
$24.61 Billion |
|
Markel Corporation
NYSE:MKL
|
$24.61 Billion |
|
Novonesis (Novozymes) A/S
CO:NSIS-B
|
$24.56 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Koninklijke Philips NV's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 12,028,000,000 to 12,006,000,000, a change of -22,000,000 (-0.2%).
- Net loss of 702,000,000 reduced equity.
- Dividend payments of 1,000,000 reduced retained earnings.
- Share repurchases of 411,000,000 reduced equity.
- Other comprehensive income increased equity by 1,046,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-702.00 Million | -5.85% |
| Dividends Paid | €1.00 Million | -0.01% |
| Share Repurchases | €411.00 Million | -3.42% |
| Other Comprehensive Income | €1.05 Billion | +8.71% |
| Other Changes | €46.00 Million | +0.38% |
| Total Change | €- | -0.18% |
Book Value vs Market Value Analysis
This analysis compares Koninklijke Philips NV's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.97x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 4.29x to 1.97x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1987-12-31 | €5.91 | €25.35 | x |
| 1988-12-31 | €6.17 | €25.35 | x |
| 1989-12-31 | €7.38 | €25.35 | x |
| 1990-12-31 | €4.65 | €25.35 | x |
| 1991-12-31 | €4.04 | €25.35 | x |
| 1992-12-31 | €2.88 | €25.35 | x |
| 1993-12-31 | €4.56 | €25.35 | x |
| 1994-12-31 | €4.85 | €25.35 | x |
| 1995-12-31 | €4.77 | €25.35 | x |
| 1996-12-31 | €1.57 | €25.35 | x |
| 1997-12-31 | €1.79 | €25.35 | x |
| 1998-12-31 | €9.92 | €25.35 | x |
| 1999-12-31 | €2.52 | €25.35 | x |
| 2000-12-31 | €15.37 | €25.35 | x |
| 2001-12-31 | €13.57 | €25.35 | x |
| 2002-12-31 | €10.25 | €25.35 | x |
| 2003-12-31 | €9.36 | €25.35 | x |
| 2004-12-31 | €10.85 | €25.35 | x |
| 2005-12-31 | €12.47 | €25.35 | x |
| 2006-12-31 | €18.24 | €25.35 | x |
| 2007-12-31 | €18.57 | €25.35 | x |
| 2008-12-31 | €14.68 | €25.35 | x |
| 2009-12-31 | €14.74 | €25.35 | x |
| 2010-12-31 | €14.87 | €25.35 | x |
| 2011-12-31 | €12.11 | €25.35 | x |
| 2012-12-31 | €11.27 | €25.35 | x |
| 2013-12-31 | €11.41 | €25.35 | x |
| 2014-12-31 | €11.05 | €25.35 | x |
| 2015-12-31 | €11.85 | €25.35 | x |
| 2016-12-31 | €12.73 | €25.35 | x |
| 2017-12-31 | €11.91 | €25.35 | x |
| 2018-12-31 | €12.13 | €25.35 | x |
| 2019-12-31 | €12.95 | €25.35 | x |
| 2020-12-31 | €12.40 | €25.35 | x |
| 2021-12-31 | €15.19 | €25.35 | x |
| 2022-12-31 | €14.39 | €25.35 | x |
| 2023-12-31 | €12.13 | €25.35 | x |
| 2024-12-31 | €12.86 | €25.35 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Koninklijke Philips NV utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -5.85%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -3.90%
- • Asset Turnover: 0.62x
- • Equity Multiplier: 2.41x
- Recent ROE (-5.85%) is below the historical average (7.20%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1987 | 3.47% | 1.02% | 1.06x | 3.22x | €-440.62 Million |
| 1988 | 3.21% | 0.95% | 1.06x | 3.20x | €-478.95 Million |
| 1989 | 4.14% | 1.38% | 1.04x | 2.88x | €-494.02 Million |
| 1990 | -34.24% | -8.12% | 1.08x | 3.90x | €-2.53 Billion |
| 1991 | 9.09% | 2.11% | 1.14x | 3.77x | €-52.60 Million |
| 1992 | -9.92% | -1.54% | 1.20x | 5.38x | €-822.03 Million |
| 1993 | 15.05% | 3.34% | 1.27x | 3.54x | €304.10 Million |
| 1994 | 14.72% | 3.48% | 1.27x | 3.33x | €320.15 Million |
| 1995 | 18.91% | 4.12% | 1.23x | 3.72x | €607.59 Million |
| 1996 | -4.23% | -0.85% | 1.26x | 3.95x | €-916.12 Million |
| 1997 | 29.46% | 7.50% | 1.29x | 3.05x | €1.70 Billion |
| 1998 | 42.63% | 19.88% | 1.08x | 1.98x | €4.61 Billion |
| 1999 | 12.19% | 5.72% | 1.07x | 2.00x | €324.67 Million |
| 2000 | 44.17% | 25.36% | 0.98x | 1.77x | €7.45 Billion |
| 2001 | -14.11% | -8.05% | 0.84x | 2.08x | €-4.46 Billion |
| 2002 | -23.03% | -10.07% | 0.99x | 2.32x | €-4.60 Billion |
| 2003 | 5.44% | 2.39% | 1.00x | 2.27x | €-580.91 Million |
| 2004 | 19.09% | 9.35% | 0.99x | 2.07x | €1.35 Billion |
| 2005 | 17.21% | 9.44% | 0.90x | 2.03x | €1.20 Billion |
| 2006 | 23.41% | 19.96% | 0.70x | 1.67x | €3.08 Billion |
| 2007 | 19.22% | 15.56% | 0.74x | 1.68x | €2.00 Billion |
| 2008 | -0.59% | -0.35% | 0.83x | 2.04x | €-1.65 Billion |
| 2009 | 2.81% | 1.77% | 0.76x | 2.09x | €-1.05 Billion |
| 2010 | 9.61% | 5.69% | 0.79x | 2.14x | €-58.60 Million |
| 2011 | -10.48% | -5.74% | 0.78x | 2.34x | €-2.53 Billion |
| 2012 | 2.03% | 0.91% | 0.85x | 2.61x | €-888.00 Million |
| 2013 | 10.42% | 5.01% | 0.88x | 2.37x | €47.60 Million |
| 2014 | 3.82% | 1.94% | 0.75x | 2.61x | €-671.70 Million |
| 2015 | 5.53% | 2.66% | 0.78x | 2.66x | €-521.20 Million |
| 2016 | 11.49% | 5.91% | 0.76x | 2.56x | €187.90 Million |
| 2017 | 13.81% | 9.32% | 0.70x | 2.11x | €457.10 Million |
| 2018 | 9.02% | 6.02% | 0.70x | 2.15x | €-118.80 Million |
| 2019 | 9.27% | 6.00% | 0.72x | 2.14x | €-91.70 Million |
| 2020 | 10.00% | 6.08% | 0.70x | 2.33x | €0.00 |
| 2021 | 22.99% | 19.35% | 0.55x | 2.14x | €1.88 Billion |
| 2022 | -12.14% | -9.02% | 0.58x | 2.32x | €-2.93 Billion |
| 2023 | -3.87% | -2.56% | 0.62x | 2.44x | €-1.67 Billion |
| 2024 | -5.85% | -3.90% | 0.62x | 2.41x | €-1.90 Billion |
Industry Comparison
This section compares Koninklijke Philips NV's net assets metrics with peer companies in the Medical Devices industry.
No peer company data available for comparison.
About Koninklijke Philips NV
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides diagnostic imaging solutions, includes magnetic resonance imaging; X-ray systems; and computed tomography (CT) systems and software comprising detector-based spectral… Read more